Search

Search Results

• Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

  Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin

  49-58

  01.01.2026

• Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis

  A.G. Turkina, O. Yu. Vinogradova, Е.G. Lomaia, B.A. Bakirov, N.M. Kalimulina, T.V. Shelekhova, I.L. Davydkin, T.I. Pospelova, O.A. Shukhov, E.Yu. Chelysheva, V.A. Shuvaev, S. Lavana, V. Khushoo, S. Apte, T.K. Dolai, R.K. Sahoo, Germes Grigorevich Chilov

  1-13

  01.01.2026

• Quality of Life and Symptom Profile in Polycythemia Vera Patients on Ruxolitinib Therapy in a Real-World Setting: Results of a Multi-Center Prospective Observational Study

  T.I. Ionova, Tatyana Pavlovna Nikitina, A.V. Proidakov, E.V. Lyurova, Е.M. Volodicheva, L.A. Mkhitaryan, Yu.P. Martinova, T.V. Chitanava, N.B. Esefeva, М.O. Ivanova, Т.I. Pospelova, A.S. Lyamkina, E.A. Knyazeva, Е.G. Lomaia, N.S. Lazorko, K.P. Novoselov, D.A. Lipatova, N.M. Porfirieva, А.D. Kulagin

  14-26

  01.01.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• CAR-T Cell Therapy in Real-World Clinical Practice: An Experience of the NN Alexandrov National Cancer Centre of Belarus

  N.E. Konoplya, Volha Aleksandrovna Kalenik, P.D. Dziameshka, E.Yu. Zharkova, T.V. Savich, T.M. Doroshenko, I.N. Seviaryn, N.M. Bobrova, A.A. Beleevsky, E.Kh. Sarydze, S.L. Polyakov

  305-314

  01.10.2025

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• Analysis of Plasma Circulating Cell-Free DNA in Acute Myeloid Leukemia Patients

  Elena Nikolaevna Voropaeva, M.V. Burundukova, I.A. Kuznetsova, P.S. Orlov, A.M. Nesterets, S.V. Minnikh, V.N. Maximov, T.I. Pospelova

  347-354

  01.10.2025

• Sociomedical Profile and Quality of Life of Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Pathogenetic Therapy

  T.I. Ionova, A.D. Kulagin, E.A. Lukina, V.V. Ptushkin, E.G. Arshanskaya, T.N. Babaeva, B.A. Bakirov, S.V. Voloshin, G.P. Dimov, O.U. Klimova, E.Yu. Komarceva, O.L. Panteleeva, R.V. Ponomarev, T.I. Pospelova, S.V. Samarina, N.O. Saraeva, K.O. Farizova, M.N. Finyakina, A.A. Shutylev, D.A. Lipatova, N.M. Porfirieva, Tatyana Pavlovna Nikitina

  197-208

  01.07.2025

• Comparative Assessment of Long-Term Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors Registered in the Russian and International Databases for Hematologic Diseases

  Anastasiya Viktorovna Beynarovich, A.L. Alyanskii, K.S. Afanaseva, L.V. Fedorova, A.M. Chekalov, E.A. Bakin, N.E. Ivanova, A.A. Golovacheva, E.V. Babenko, M.A. Estrina, O.G. Smykova, Yu.Yu. Vlasova, E.V. Morozova, N.B. Mikhailova, A.G. Smirnova, S.N. Bondarenko, M.D. Vladovskaya, D.E. Pevtsov, A.A. Vitrishchak, I.S. Moiseev, A.D. Kulagin, L.S. Zubarovskaya, B.V. Afanasyev

  257-269

  01.07.2025

• Which Calculations Are Required for Treating Patients with Multiple Myeloma?

  Aleksander Sergeevich Luchinin, A.A. Semenova

  218-226

  01.07.2025

• Efficacy and Safety of Ruxolitinib in Primary Myelofibrosis Patients with Abdominal Thrombotic Complications: A Case Series

  Yu.P. Martinova, E.V. Borovitskaya, S.S. Lebedeva, E.R. Efimova, O.E. Filippova, K.M. Chernysh, A.P. Smaglyuk, L.I. Napso, N.V. Novospasskaya, L.V. Kucheryavykh, Tamara Vangelevna Chitanava

  250-256

  01.07.2025

• Comparative Efficacy Analysis of Mobilization and Collection of Autologous Hematopoietic Stem Cells in Patients with Lymphoproliferative Disorders and Multiple Sclerosis

  Oksana Vladimirovna Fedyk, V.O. Sarzhevskii, D.A. Fedorenko, V.Ya. Mel’nichenko, Yu.N. Dubinina, N.E. Mochkin, E.G. Smirnova, D.S. Kolesnikova, A.E. Bannikova

  51-58

  01.07.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

  Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin

  153-162

  01.04.2025

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure

  Ekaterina Alekseevna Karimova, E.I. Zhelnova, E.A. Baryakh, E.Yu. Grishina, E.N. Zotina, D.E. Gagloeva, V.N. Yakimets, O.L. Kochneva, E.N. Misyurina

  171-176

  01.04.2025

• Theoretical and Practical Aspects of Studying the Fractions of BAALC-Expressing Hematopoietic Stem Cells in Acute Myeloid Leukemia Patients with FLT3 Mutations

  Nikolai Nikolaevich Mamaev, M.M. Kanunnikov, A.I. Shakirova, I.M. Barkhatov, A.M. Sadykov, B.I. Ayubova, T.L. Gindina, J.J. Vlasova, S.N. Bondarenko

  73-85

  01.01.2025

• Efficacy and Toxicity of Cytarabine + G-CSF, Cyclophosphamide + G-CSF, and Plerixafor + G-CSF Mobilization of Autologous Hematopoietic Stem Cells in Hematologic Malignancy Patients with Predicted Poor Collection

  Svetlana Sergeevna Elkhova, L.V. Filatova, I.S. Zyuzgin, S.A. Volchenkov, L.A. Kramynin, T.Yu. Semiglazova

  86-91

  01.01.2025

• Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

  Yana Konstantinovna Mangasarova, R.R. Abdurashidova, A.U. Magomedova, O.V. Margolin, E.S. Nesterova, L.G. Gorenkova, M.O. Bagova, E.A. Fastova, D.S. Belkina, A.M. Kovrigina, N.G. Gabeeva, D.A. Koroleva, S.K. Kravchenko, Yu.A. Chabaeva, E.E. Zvonkov

  335-346

  01.10.2024

• The Efficacy of Bortezomib, Lenalidomide, and Dexamethasone Combination as Induction Therapy in Patients with Multiple Myeloma Complicated by the End-Stage Renal Disease

  Sergei Vyacheslavovich Semochkin, E.I. Zhelnova, V.I. Kazey, A.V. Cherkasova, A.G. Nikiforova, N.F. Frolova, E.A. Baryakh, K.V. Yatskov, E.A. Karimova, O.N. Kotenko, E.N. Misyurina

  360-369

  01.10.2024

• Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review

  Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis

  404-414

  01.10.2024

• Primary Immune Thrombocytopenia in Children: An Analysis of the Therapy Efficacy in Compliance with the National Clinical Guidelines

  Maksim Yurevich Rykov, M.Yu. Rykov

  285-290

  01.07.2024

• KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

  Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva

  256-265

  01.07.2024

• Multiple Myeloma: Simulation of Therapy Scenarios Using the Monte Carlo Method

  Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin

  246-255

  01.07.2024

• National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)

  Anait Levonovna Melikyan, I.N. Subortseva, A.M. Kovrigina, V.A. Shuvaev, E.V. Morozova, E.G. Lomaia, V.V. Baykov, O.Yu. Vinogradova, S.V. Gritsaev, T.I. Ionova, P.I. Kuznetsova, L.A. Kuzmina, I.S. Martynkevich, T.A. Mitina, E.S. Polushkina, T.I. Pospelova, M.A. Sokolova, A.B. Sudarikov, M.M. Tanashyan, A.G. Turkina, Yu.V. Shatokhin, R.G. Shmakov, E.N. Parovichnikova

  291-334

  01.07.2024

• Nivo-DHAP Combined with Subsequent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Trial (ClinicalTrials.gov, NCT04091490)

  V.O. Sarzhevskii, Aisel Akifovna Mamedova, N.E. Mochkin, E.A. Demina, A.A. Spornik, A.A. Samoilova, V.S. Bogatyrev, A.A. Rukavitsyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko, N.B. Mikhailova, E.S. Borzenkova, L.V. Stelmakh, Yu.R. Zalyalov, A.A. Semenova, G.S. Tumyan, M.A. Danilova, O.A. Konova, N.A. Falaleeva, AYu Terekhova, M.A. Vernyuk, A.M. Chervontseva, L.S. Khairullina, A.A. Maslov, I.B. Lysenko, Yu.A. Alekseeva, E.S. Pavlyuchenko, A.A. Mirsaitov, A.A. Zverkova, I.V. Ishmatova, S.A. Volchenkov, M.S. Motalkina, I.S. Zyuzgin

  1-10

  17.05.2024

• Ibrutinib in Chronic Lymphocytic Leukemia Therapy for High- and Very-High-Risk Patients over 60 Years of Age

  Nadezhda Viktorovna Kurkina, E.A. Repina, E.I. Gorshenina, V.O. Kurkina, P.V. Volkova, A.A. Repin

  37-42

  17.05.2024

• Treatment of Patients with Local Stages of Newly Diagnosed Classical Hodgkin Lymphoma: A Literature Review, Current Approaches, and Our Own Experience

  Evgeniya Viktorovna Paramonova, Yu.I. Klyuchagina, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.V. Arakelyan, A.A. Semenova, E.A. Demina, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, G.S. Tumyan

  27-36

  17.05.2024

• Comparative Efficacy of Autologous Hematopoietic Stem Cell Mobilization Regimens in Multiple Myeloma Patients

  Ivan Ivanovich Kostroma, Zh.V. Chubukina, V.A. Yudina, N.A. Romanenko, E.I. Stepchenkova, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  43-49

  17.05.2024

• Treatment of Diffuse Large B-Cell Lymphoma at the Moscow City Clinical Hospital No. 52: A Retrospective Clinical Trial Based on the Single-Center Experience and Analysis of Data from Its In-House Registry

  Marat Albertovich Mingalimov, E.A. Baryakh, Yu.Yu. Polyakov, E.N. Misyurina, E.I. Zhelnova, K.V. Yatskov, A.B. Makeshova, T.N. Tolstykh, TS Chudnova, D.D. Ivanova, O.L. Kochneva, I.V. Samsonova, M.A. Lysenko

  11-17

  17.05.2024

• Pharmacological Protection of Ovaries During Program Drug Chemotherapy in Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Patients

  I.E. Antukh, Valeriya Olegovna Shpirko, T.A. Nazarenko, Ya.O. Martirosyan, A.M. Biryukova, S.V. Khokhlova, G.S. Tumyan

  59-65

  17.05.2024

• Therapy Optimization in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Efficacy and Safety of the R-SD-EPOCH ± HDMTX Program Under Single-Center Non-Randomized Prospective Clinical Trial (Preliminary Results)

  Marat Albertovich Mingalimov

  173-179

  01.04.2024

• Treatment of Aggressive Systemic Mastocytosis and Mast Cell Leukemia. Literature Review and Case Reports

  Vsevolod Gennadevich Potapenko, E.V. Morozova

  180-194

  01.04.2024

• Supportive Therapy in Multiple Myeloma: Practical Recommendations

  Maksim Valerevich Solovev, M.V. Soloveva, L.P. Mendeleeva

  426-448

  28.09.2023

• Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

  Anna Anatolevna Spornik, N.S. Vasilev, A.A. Samoilova, A.A. Mamedova, V.S. Bogatyrev, E.G. Smirnova, A.A. Bannikova, A.A. Rukavitsyn, N.S. Shorokhov, N.E. Mochkin, V.O. Sarzhevskii, E.A. Demina, V.Ya. Melnichenko

  370-379

  28.09.2023

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy

  A.G. Turkina, Elena Andreevna Kuzmina

  311-320

  09.06.2023

• Multiple Myeloma Complicated by Bone Plasmacytomas: Pathogenesis, Clinical Features, Treatment Approaches (A Literature Review)

  Elizaveta Andreevna Mamaeva, M.V. Solov’eva, L.P. Mendeleeva

  303-310

  09.06.2023

• Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients Aged over 60 Years

  Ivan Ivanovich Kostroma, V.A. Yudina, R.R. Sabitova, E.S. Stepchenkova, Zh.V. Chubukina, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  287-293

  09.06.2023

• Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study

  Yana Konstantinovna Mangasarova, T.N. Moiseeva, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, F.E. Babaeva, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, L.S. Al-Radi, E.I. Dorokhina, E.M. Volodicheva, V.A. Lapin, O.S. Samoilova, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov

  280-286

  09.06.2023